Equitable Trust Co. Has $485,000 Stock Holdings in Cardinal Health, Inc. $CAH

Equitable Trust Co. grew its holdings in Cardinal Health, Inc. (NYSE:CAH) by 2.7% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 2,888 shares of the company’s stock after purchasing an additional 76 shares during the period. Equitable Trust Co.’s holdings in Cardinal Health were worth $485,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. MassMutual Private Wealth & Trust FSB increased its stake in shares of Cardinal Health by 3.6% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock worth $297,000 after purchasing an additional 62 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its stake in shares of Cardinal Health by 0.4% in the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company’s stock worth $2,991,000 after purchasing an additional 69 shares in the last quarter. Perigon Wealth Management LLC increased its stake in shares of Cardinal Health by 3.2% in the 2nd quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company’s stock worth $389,000 after purchasing an additional 72 shares in the last quarter. Community Bank & Trust Waco Texas increased its stake in shares of Cardinal Health by 1.3% in the 2nd quarter. Community Bank & Trust Waco Texas now owns 5,598 shares of the company’s stock worth $940,000 after purchasing an additional 74 shares in the last quarter. Finally, Yarger Wealth Strategies LLC increased its stake in Cardinal Health by 4.3% in the 2nd quarter. Yarger Wealth Strategies LLC now owns 1,835 shares of the company’s stock worth $308,000 after buying an additional 76 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of NYSE:CAH opened at $155.72 on Thursday. Cardinal Health, Inc. has a 1 year low of $106.98 and a 1 year high of $168.44. The business has a 50 day simple moving average of $151.90 and a two-hundred day simple moving average of $151.48. The firm has a market capitalization of $37.00 billion, a PE ratio of 24.14, a price-to-earnings-growth ratio of 1.30 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. During the same quarter in the previous year, the business earned $1.84 earnings per share. The company’s revenue for the quarter was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were paid a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend was Wednesday, October 1st. Cardinal Health’s payout ratio is currently 31.63%.

Insider Activity

In other news, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the completion of the sale, the insider owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. The trade was a 47.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Jessica L. Mayer sold 38,078 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the sale, the insider directly owned 48,457 shares of the company’s stock, valued at $7,211,370.74. This represents a 44.00% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 271,676 shares of company stock valued at $40,489,525. Insiders own 0.12% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have commented on CAH. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Evercore ISI cut their price objective on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research report on Wednesday, August 13th. Leerink Partners raised their price objective on Cardinal Health from $186.00 to $187.00 and gave the company an “outperform” rating in a research report on Monday, October 6th. Wells Fargo & Company restated an “overweight” rating and set a $185.00 price objective (up previously from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $166.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.